Literature DB >> 6765904

Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency.

A Ganer, B Knobel, C H Fryd, E A Rachmilewitz.   

Abstract

Methemoglobinemia and hemolysis are well-known side effects after using high doses of dapsone (4,4'-diaminodiphenylsulfone). Their occurrence after low doses of the drug, and subsequent investigation, revealed the presence of hemoglobin Hasharon, and low content of NADH-dependent methemoglobin reductase in five members of an East European ashkenazic Jewish family.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6765904

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  8 in total

1.  The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

Authors:  M D Coleman; A K Scott; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

2.  Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.

Authors:  M D Coleman; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

4.  The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.

Authors:  M D Coleman; L E Rhodes; A K Scott; J L Verbov; P S Friedmann; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 5.  Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.

Authors:  Bernard J Brabin; Teunis A Eggelte; Monica Parise; Francine Verhoeff
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

6.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 7.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

Review 8.  Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians.

Authors:  Muhammad Abdul Mabood Khalil; Muhammad Ashhad Ullah Khalil; Taqi F Taufeeq Khan; Jackson Tan
Journal:  J Transplant       Date:  2018-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.